Assessment of Oncological Safety, Quality of Life, and Environmental Impact of the Green Breast Surgery Protocol

Breast Cancer (BC) is the primary oncological diagnosis in women, with the annual incidence expected to exceed 3 million new cases by 2040 due to population growth and aging. During the COVID-19 pandemic, novel methods were adopted worldwide to provide continuous patient care, including telehealth, fast-track protocols such as awake surgery in breast cancer. These innovative techniques allowed for improved access to care, and additionally reduced emissions with environmental impact, better resource utilization, and improved continuity of care, but their impact post-pandemic era has not been i

Trial Details

NCT ID
NCT06624917
Phase
NA
Sponsor
University of Rome Tor Vergata
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Green Breast Surgery Protocol
Locations (sample)
  • Roma, Italy|44.99364,11.10642

Key Eligibility Criteria

  • Patients candidates for Breast Conserving Treatment
  • ASA score I-II
  • Availability to Telehealth assessment in the postoperative period

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →